Disease Area Offered: Toxicology

Nagi Bioscience

We are a Swiss high-tech company developing and offering cutting-edge biological testing solutions that enable scientists to generate insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our technologies are designed to integrate seamlessly into existing lab environments, enhancing efficiency, accuracy, and reproducibility.

TAK-994 mechanistic investigation into drug-induced liver injury

Expression Analysis of Exosomal MicroRNAs in Chlorpromazine Treated Human Hepatic Spheroids: A Promising Tool for Novel Drug-Induced Liver Injury Biomarker Discovery

Physiological liver microtissue 384-well microplate system for preclinical hepatotoxicity assessment of therapeutic small molecule drugs

Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs

Deciphering per- and polyfluoroalkyl substances mode of action: comparative gene expression analysis in human liver spheroids

Transcriptomic analysis in liver spheroids identifies a dog-specific mechanism of hepatotoxicity for amcenestrant

Generation of uniform liver spheroids from human pluripotent stem cells for imaging-based drug toxicity analysis

Differential basolateral-apical distribution of scavenger receptor, class B, type I in cultured cells and the liver